MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings

Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MGRX?

The average price target is $0.00.

MGRX Key Metrics

Key financial metrics for MGRX
MetricValue
Price$0.40
Market Cap$6.87M
P/E Ratio-0.19
EPS$-2.17
Dividend Yield0.00%
52-Week High$7.66
52-Week Low$0.16
Volume69
Avg Volume0
Revenue (TTM)$456.02K
Net Income$-20.64M
Gross Margin54.91%

MGRX Analyst Consensus

MGRX analyst coverage data. Average price target: $0.00.

Latest MGRX News

Recent MGRX Insider Trades

  • JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
  • JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
  • JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.

Common questions about MGRX

What do analysts rate MGRX?
The average price target is $0.00.
Does Rallies show MGRX price targets?
Yes. Rallies tracks MGRX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MGRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.
MGRX

MGRX